About: The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 28 March 2011

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) наукова стаття, опублікована в березні 2011 (uk) مقالة علمية نشرت في 28 مارس 2011 (ar) scientific article published on 28 March 2011 (en) artículu científicu espublizáu en marzu de 2011 (ast)
publication date	wds:Q37858846-6499521C-7C7E-481F-99EA-56D818AB54E1
publication date	2011-03-28 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37858846-D91FAB70-1739-4163-94E1-5354D16567F3
language of work or name	English
cites work	wds:Q37858846-05492603-7006-4554-8155-671D8F4B16CF wds:Q37858846-08FAA6D2-2FD8-4034-B408-D948BAEE3E74 wds:Q37858846-0D54C93B-B5D7-46A4-BAEE-2A895C2602F1 wds:Q37858846-172BAB9E-6676-408F-BE24-486B89038B30 wds:Q37858846-1F453C3B-E453-4163-9ADD-7E861062C1C3 wds:Q37858846-2231B20C-224E-4BE1-90D9-92CB8C01C81A wds:Q37858846-2DF304A4-AB88-4D8F-8961-5B2C0CBBA65C wds:Q37858846-5B6B5FD2-AFE8-497E-BDC5-E2AF1F5472E5 wds:Q37858846-6442B841-9225-43F9-9C95-0DA05256A14C wds:Q37858846-69C2B5AD-532E-40C6-9E8D-577A2ED65387 wds:Q37858846-6CE4AB85-D8CB-40AD-B936-A39FE9B9914F wds:Q37858846-6FB1AE08-9CE9-4BD6-81A5-4AEC697E7EA3 wds:Q37858846-77273C4D-1912-402B-AE3C-15EAD1307BD0 wds:Q37858846-79FC03CB-DCF1-497F-B3BB-E1AF05560E5F wds:Q37858846-7E180BB4-5EAB-4DA1-A2BD-A65196B70B3D wds:Q37858846-832C143F-6367-411E-AC3B-8337AFD46BE6 wds:Q37858846-86C35B52-8B85-48B6-8F6C-35FD5251DE59 wds:Q37858846-8C6272E0-5B9B-4955-8976-9DCD8EFCC4ED wds:Q37858846-99AD11DF-4E62-465D-B477-A8841A6DEED8 wds:Q37858846-9DB5923F-B96C-496A-8C66-7CCC14DFD15B wds:Q37858846-A04875C6-C792-4237-848C-D5F6F61CA2AC wds:Q37858846-A32445AE-1A95-4BC7-8429-8A971E004B4F wds:Q37858846-AA588871-EA8D-4DA7-AB9E-4AFAEE6D96E4 wds:Q37858846-ACC763D0-F78B-4087-89DD-3C0094FFD84E wds:Q37858846-B00B2C56-EC18-4131-9572-359231701C31 wds:Q37858846-B69CDCB4-0C8C-43F0-83B2-1FAE5E1F7D84 wds:Q37858846-BFC910CC-9666-498C-80DA-BBA355568F3C wds:Q37858846-D7F38233-8827-4C69-8391-7FA89A1687A1 wds:Q37858846-DCA7CC3B-5140-4CD9-A149-92B7F7575185 wds:Q37858846-F7850EE3-E802-4F1F-BF72-666F6AE16E04 wds:Q37858846-FEE01D60-A4BC-4A76-B8F3-8A7D7389D7ED
cites work	Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial The efficacy and safety of ticlopidine and aspirin in non-whites: analysis of a patient subgroup from the Ticlopidine Aspirin Stroke Study Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials Statistics in medicine--reporting of subgroup analyses in clinical trials. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review Relationship between funding source and conclusion among nutrition-related scientific articles Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration Pharmaceutical industry sponsorship and research outcome and quality: systematic review Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ The uncertainty principle and industry-sponsored research Subgroup analysis and other (mis)uses of baseline data in clinical trials Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes Dealing with heterogeneity of treatment effects: is the literature up to the challenge? Uneasy alliance--clinical investigators and the pharmaceutical industry OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Statistical problems in the reporting of clinical trials. A survey of three medical journals. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials Multiplicity in randomised trials II: subgroup and interim analyses Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? Misuse of Baseline Comparison Tests and Subgroup Analyses in Surgical Trials Clinical trial data: to disclose or not to disclose?
author name string	wds:Q37858846-0982DFF7-39C5-4734-8B81-B0107207542F wds:Q37858846-0A9E0051-A1F8-4691-AF57-8478AC965CF6 wds:Q37858846-0DC8A50A-A57D-4739-A44A-589EC48D8E3D wds:Q37858846-1049C05A-E7D9-478F-9D97-AA90FBD77234 wds:Q37858846-1A95AC9C-168A-419C-B6B5-9229E241D70F wds:Q37858846-C096BCC1-0AD4-4FF4-AE79-3F0871645E0A wds:Q37858846-C163BBC5-D531-4145-8925-12DD0326323F wds:Q37858846-DDF41181-2874-4E15-854D-9FE9B3D1E283
author name string	Dirk Bassler Xin Sun Stephen D Walter Bradley C Johnston John J You Philipp Dahm Neil D Dattani Jessica Truong
rdfs:label	The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software